ASS Dexcel Protect 75 mg Tablets 20 pcs
Supports cardiovascular health and helps prevent blood clots
Category: Cardiovascular / Antiplatelet
Purpose: Reduces the risk of heart attack, stroke, and vascular complications
What It Is
ASS Dexcel Protect contains acetylsalicylic acid (aspirin) 75 mg, a low-dose antiplatelet medication that helps prevent blood clots by reducing platelet aggregation. It is commonly used in adults at risk of cardiovascular events, such as heart attack or stroke, and as part of long-term cardiovascular preventive therapy.
✅ Key Benefits
-
Helps reduce the risk of heart attack and stroke
-
Supports healthy blood flow by preventing clot formation
-
Suitable for long-term cardiovascular preventive therapy
-
Convenient tablet form for daily use
-
Well-tolerated in low-dose therapy
Use & Dosage
Adults: Take 1 tablet daily, or as directed by your healthcare professional.
Swallow whole with water, preferably after meals to minimize stomach irritation.
Do not exceed the recommended dose without medical advice.
⚠️ Safety & Precautions
-
Not suitable for individuals with active stomach ulcers, bleeding disorders, or aspirin allergy.
-
Consult a doctor if pregnant, breastfeeding, or taking other medications.
-
May increase bleeding risk — use with caution during surgery or injury.
-
Avoid use in children and adolescents with viral infections due to the risk of Reye’s syndrome.
-
Use under medical supervision for long-term therapy.
Product Details
Form: Tablets
Active Ingredient: Acetylsalicylic acid (aspirin) 75 mg
Target Group: Adults requiring antiplatelet therapy
Pack Size: 20 pcs
Buy ASS Dexcel Protect 75 mg Tablets 20 pcs
Support your cardiovascular health and reduce the risk of blood clots with ASS Dexcel Protect — available now at Pharmeu.
SEO Keywords:
ASS Dexcel Protect 75 mg, low-dose aspirin tablets, cardiovascular protection, blood clot prevention, heart attack prevention, stroke prevention tablets, acetylsalicylic acid 75 mg, daily aspirin therapy, antiplatelet tablets, ASS Dexcel 20 pcs
.
